+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Switzerland Healthcare, Regulatory and Reimbursement Landscape - CountryFocus

  • ID: 4586861
  • Report
  • July 2021
  • Region: Switzerland
  • 174 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher, the industry analysis specialist, has released its latest report, “Switzerland Healthcare, Regulatory and Reimbursement Landscape - CountryFocus”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Switzerland. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher’s team of industry experts.

The Swiss pharmaceutical industry is one of the major industries of the country. In 2020, it amounted to about 27.7% of Switzerland’s total exports, making it the country’s largest exporting industry. In terms of Swiss Francs, the country’s pharmaceutical market increased from CHF5.93B in 2013 to CHF6.84B in 2020. It is estimated to increase at a Compound Annual Growth Rate (CAGR) of 1.9% to CHF7.51B in 2025. In the terms of US dollars, the Swiss pharmaceutical market increased from $6.40B in 2013 to $7.28B in 2020, which is estimated to increase at a CAGR of 1.3% to $7.75B in 2025. High expenditure on pharmaceutical R&D and the presence of major pharmaceutical companies have propelled the growth of the pharmaceutical industry. The medical devices market in Switzerland was valued at $2.27B in 2015, which increased to2.88B in 2020 at a CAGR of 5%. The market is expected to grow at a CAGR of 3% from $3.18B in 2021 to $3.61B in 2025.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Switzerland, and includes:
  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Roche, Pfizer, Novartis, Bayer, and Octapharma.
  • Profiles and SWOT analyses of the major players in the medical device market: Roche, Abbott, Medtronic, Zimmer Biomet, and Smith-Nephew.
  • An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, healthtech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in Switzerland healthcare market
Reasons to Buy

This report will enhance your decision-making capability by allowing you to:
  • Develop business strategies by understanding the trends shaping and driving Switzerland healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Switzerland healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
Note: Product cover images may vary from those shown

1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Executive Summary
2.2 Key Highlights - Facts about Switzerland Healthcare Market
2.3 Key Highlights: Healthcare Startups in Switzerland
2.4 Key Events: Switzerland Pharmaceutical News, 2015-2021
2.5 Key Events: Switzerland Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, Switzerland, 2020

3. Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Key Areas for Building a Strong Pharma hub in Switzerland, Vision: 2030
3.3 Pharmaceutical Market - Exports
3.4 Pharmaceutical Market - Imports
3.5 Pharmaceutical Market - Supply Channels, Switzerland
3.6 Pharmaceutical Market - Illegal Import of Medicines, Switzerland
3.7 Pharmaceutical Market - Market Segments
3.8 Major Therapeutic Areas, Switzerland
3.9 COVID-19 Epidemiology, Switzerland
3.10 COVID-19 Impact and Developments, Switzerland
3.11 COVID-19 Clinical Trials Landscape, Switzerland
3.12 Pharmaceutical Market - Major Players

4. Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players

5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers

6. Deal Analysis
6.1 Deal Analysis: Pharmaceutical Market, Switzerland, 2019-2021
6.2 Deal Analysis: Medical Device Market, Switzerland, 2019-2021

7. HealthTech Landscape
7.1 HealthTech Landscape, Switzerland
7.2 Adoption of Technology in Healthcare, Switzerland
7.3 HealthTech Deals Landscape, Switzerland
7.4 Key HealthTech Deals, Switzerland
7.5 Digital Health Regulations, Switzerland
7.6 HealthTech Landscape: Benefits and Risks, Switzerland

8. Market Access
8.1 Overview of Healthcare System, Switzerland
8.2 Drug Reimbursement Process, Switzerland
8.3 Overview of Insurance Providers, Switzerland
8.4 Out-of-Pocket Co-Payments and Safety Nets, Switzerland
8.5 Out-of-Pocket Spending and Pharmaceutical Price Index, Switzerland
8.6 Pricing Policies, Switzerland
8.7 Regulatory Landscape, Switzerland
8.7.1 Overview of Regulatory Agencies, Switzerland
8.7.2 Marketing Authorization for Pharmaceutical Products, Switzerland
8.7.3 Marketing Authorization for Generic Medicines, Switzerland
8.7.4 Marketing Authorization for Biosimilars, Switzerland
8.7.5 Marketing Authorization for Medical Devices, Switzerland
8.7.6 Export and Import Regulations, Switzerland
8.7.7 Intellectual Property Rights, Patent, Switzerland
8.7.8 Intellectual Property Rights, Trademark, Switzerland
8.7.9 Clinical Trial Regulation Process, Switzerland
8.7.10 Pharmaceutical Clinical Trials Landscape, Switzerland
8.7.11 Medical Devices Clinical Trials Landscape, Switzerland
8.7.12 Pharmacy License Regulations, Switzerland
8.7.13 Online Pharmacy Regulations, Switzerland
8.7.14 Pharmaceutical Advertisement Regulations, Switzerland
8.7.15 Labeling and Packaging Regulations, Switzerland

9. Country Healthcare Landscape
9.1 Healthcare Policy Highlights, Switzerland
9.2 Healthcare Facilities, Switzerland
9.3 Healthcare Parameters, Switzerland
9.4 Life Expectancy and Immunization Rate, Switzerland
9.5 Environmental Health, Switzerland
9.6 Healthcare Personnel, Switzerland
9.7 Disease Burden, US Switzerland
9.8 Healthcare Expenditure, Switzerland
9.9 Healthcare Spending Components and Pharmaceutical Spending, Switzerland

11 Trade Associations, Conferences, and Trade Fairs, Switzerland

12 Opportunities and Challenges

13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About the Publisher
13.4 Contact the Publisher
13.5 Disclaimer

List of Tables
Table 1: Pharmaceutical Distribution Channels, Switzerland, 2019
Table 2: Confiscated Shipments: Trend Over the Last Three Years, Switzerland, 2018-2020
Table 3: Origin of Illegal Imports by Country/Region, Switzerland, 2019-2020
Table 4: Confiscated Shipments by Product Categories, Switzerland, 2019-2020
Table 5: Approved Biosimilars, Switzerland, 2017-2019
Table 6: Market Share of Medicines by Therapeutic Indicator Areas, Switzerland, 2019
Table 7: COVID-19 Indicators (Number of Cases), Switzerland and Global, January 2020-July 2021
Table 8: COVID-19-Related Travel Restrictions, Switzerland, 2020-2021
Table 9: Available COVID-19-Vaccines, Switzerland, 2020-2021
Table 10: Available COVID-19 IVD products, Switzerland, 2020-2021
Table 11: Medical Devices Market, Switzerland, Major Segments ($M), 2020
Table 12: Hospital Supplies Market, Switzerland, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 13: General Surgery Devices Market, Switzerland, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 14: Orthopedic Devices Market, Switzerland, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 15: In vitro Diagnostic Devices Market, Switzerland, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 16: Wound care Management Devices Market, Switzerland, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 17: Licensed Digital Health Technologies, Switzerland, 2014-2017
Table 18: List of Most Expensive and Least Expensive Cantons, Switzerland
Table 19: Typical Patient Copayments and Safety Nets, Switzerland, 2016
Table 20: Fee for Marketing Authorization of Pharmaceutical Products, Switzerland, 2018
Table 21: Patent Application Fee, Switzerland, 2019
Table 22: Trademark Application Fee, Switzerland, 2019
Table 23: Clinical Trial Application Fee, Switzerland, 2019
Table 24: Trade Fairs, Switzerland

List of Figures
Figure 1: Pharmaceutical Market, Switzerland, Revenue ($B and CHF B), 2013-2020
Figure 2: Medical Devices Market, Switzerland, Revenue ($B), 2015-2020
Figure 3: Healthcare Start-Ups in Switzerland, 2020
Figure 4: Country Profile, Switzerland, 2020
Figure 5: Pharmaceutical Market, Switzerland, Revenue ($B), 2011-2020
Figure 6: Pharmaceutical Market, Switzerland, Revenue Forecast ($B), 2021-2025
Figure 7: Key Areas for Building a Strong Pharma Hub, Switzerland, Vision: 2030
Figure 8: Pharmaceutical Exports ($B), Switzerland, 2011-2020
Figure 9: Top Export Partners, Switzerland, 2020
Figure 10: Pharmaceutical Imports ($B), Switzerland, 2011-2020
Figure 11: Top Import Partners, Switzerland, 2020
Figure 12: Pharmaceutical Supply Channel, Switzerland, 2020
Figure 13: Reasons for Gaps in Medicine Supply, Switzerland, 2020
Figure 14: Generic Drugs Usage (% Share by Volume), Switzerland, 2010-2020
Figure 15: Generic Drugs Usage (% Share by Value), Switzerland, 2010-2020
Figure 16: Self-Medication Market, Switzerland, Revenue ($M), 2011-2019
Figure 17: Self-Medication Market by Drug Category, Revenue ($M), Switzerland, 2019
Figure 18: Major Therapeutic Product Categories by Number of Drugs Authorized, Switzerland, 2019
Figure 19: Major Therapeutic Areas by Pharmaceutical Sales ($M), Switzerland, 2018-2020
Figure 20: Market Share of Medicines by Therapeutic Indicator Areas, Switzerland, 2019
Figure 21: COVID-19 (Number of Cases), Switzerland, 2020-2021
Figure 22: COVID-19 (Number of Deaths), Switzerland, 2020-2021
Figure 23: COVID-19 Fiscal Stimulus Timeline, Switzerland, 2020-2021
Figure 24: COVID-19 Vaccine Administration, Number of Vaccines Administered, Switzerland, 2021
Figure 25: Top COVID-19 Markets by Product Categories (Number of Available Marketed Products), Switzerland, 2020-2021
Figure 26: Top COVID-19 IVD Products by Device Class (Number of Available Marketed Products), Switzerland, 2020-2021
Figure 27: COVID-19 Clinical Trials Sponsors by Count, Switzerland, 2020-2021
Figure 28: COVID-19 Clinical Trials Count by Phase, Switzerland, 2020-2021
Figure 29: COVID-19 Clinical Trials Count by Trial Status, Switzerland, 2020-2021
Figure 30: Medical Devices Market, Switzerland, Revenue ($B), 2015-2020
Figure 31: Medical Devices Market, Switzerland, Revenue Forecast ($B), 2021-2025
Figure 32: Medical Devices Market, Switzerland, Major Segments (%), 2020
Figure 33: Hospital Supplies Market, Switzerland, Revenue ($M), 2015-2022
Figure 34: Hospital Supplies Market, Switzerland, Market Share of Major Players (%), 2020
Figure 35: General Surgery Devices Market, Switzerland, Revenue ($M), 2015-2022
Figure 36: General Surgery Devices Market, Switzerland, Market Share of Major Players (%), 2020
Figure 37: Orthopedic Devices Market, Switzerland, Revenue ($M), 2015-2022
Figure 38: Orthopedic Devices Market, Switzerland, Market Share of Major Players (%), 2020
Figure 39: In vitro Diagnostic Devices Market, Switzerland, Revenue ($M), 2015-2022
Figure 40: In vitro Diagnostic Devices Market, Switzerland, Market Share of Major Players (%), 2020
Figure 41: Wound care Management Devices Market, Switzerland, Revenue ($M), 2015-2022
Figure 42: Wound care Management Devices Market, Switzerland, Market Share of Major Players (%), 2020
Figure 43: Diagnostic Market, Switzerland, Revenue ($M), 2015-2020
Figure 44: Diagnostic Market, Switzerland, Revenue Forecast ($M), 2021-2025
Figure 45: Medical Devices Market, Switzerland, Revenue ($B) of Major Companies, 2020
Figure 46: Deal Value and Deal Count, Pharmaceutical Market, Switzerland, 2019-2021
Figure 47: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Switzerland, 2019-2021
Figure 48: Deal Value and Deal Count, Subtypes, Pharmaceutical Market, Switzerland, 2019-2021
Figure 49: Top Therapy Areas by Deal Value, Pharmaceutical Market, Switzerland, 2019-2021
Figure 50: Top Therapy Areas by Deal Count, Pharmaceutical Market, Switzerland, 2019-2021
Figure 51: Mergers and Acquisitions by Quarter, Pharmaceutical Market, Switzerland, 2019-2021 (by Value and by Number)
Figure 52: Venture Financing by Quarter, Pharmaceutical Market, Switzerland, 2019-2021 (by Value and by Number)
Figure 53: Deal Value and Deal Count, Medical Devices Market, Switzerland, 2019-2021
Figure 54: Deal Value and Deal Count, Subtypes, Medical Devices Market, Switzerland, 2019-2021
Figure 55: Deal Value and Deal Count, Quarterly, Medical Devices Market, Switzerland, 2019-2021
Figure 56: Top Equipment Sectors by Deal Value, Medical Devices Market, Switzerland, 2019-2021
Figure 57: Top Equipment Sectors by Deal Count, Medical Devices Market, Switzerland, 2019-2021
Figure 58: Mergers and Acquisitions by Quarter, Medical Devices Market, Switzerland, 2019-2021 (by Value and by Number)
Figure 59: Venture Financing by Quarter, Medical Devices Market, Switzerland, 2019-2021 (by Value and by Number)
Figure 60: Swiss Digital Health Association Ecosystem, Switzerland, 2020
Figure 61: Industrial Technology Facilities, Switzerland, 2020
Figure 62: Swiss Digital Health Start-Up Map, Switzerland, 2021
Figure 63: Deal Value ($M), HealthTech, Switzerland, 2019-2021
Figure 64: Deal Count (Number of Deals), HealthTech, Switzerland, 2019-2021
Figure 65: Key Health Sector Organizations, Switzerland
Figure 66: Overview of Health System, Switzerland, 2020
Figure 67: Reimbursement Process, Switzerland, 2015
Figure 68: Out-of-Pocket Spending ($ per Capita), Switzerland, 2011-2019
Figure 69: Change in Pharmaceutical Price Index (2015 = 100), Switzerland, 2011-2020
Figure 70: Authorized Medicinal Products by Indications, Swissmedic, Switzerland, 2020
Figure 71: Organization Structure, Swissmedic, Switzerland, 2021

Note: Product cover images may vary from those shown
Adroll
adroll